Alnylam has the FDA approval it sought for Amvuttra in a form of cardiomyopathy associated with rare disease ATTR amyloidosis ...

Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

“The latest COVID-19 booster available in New Zealand is the Pfizer-BioNTech’s Comirnaty mRNA vaccine. This targets the Omicron JN.1 variant which is the most common strain currently circulating. This ...

D r. Francis Collins led the U.S. National Institutes of Health (NIH), the world’s largest funder of biomedical research, ...

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio of products spanning ...

Former SVP and Franchise Head for US Oncology at Jazz Pharmaceuticals, with established track record for leading a portfolio ...

Shares in the consumer health group - originally a joint venture between Pfizer and GSK - are up nearly a fifth since it joined the stock market in 2022.

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

Join our Discord server for a chat. Note: Always select the same GitHub tag as the released version you use to ensure you have the correct example configuration and documentation. The main branch ...

Back in 2021, at the height of the pandemic, scientists at Pfizer revealed the development of a novel antiviral molecule, ...

In this article, we are going to take a look at where Pfizer Inc (NYSE:PFE) stands against other stocks that market experts ...